Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents

NCT06902792 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Histiocytosis, Langerhans-Cell

Interventions

DRUG: treated group

Sponsor

Second Affiliated Hospital of Wenzhou Medical University